130 related articles for article (PubMed ID: 1974396)
21. Dissociation of hypnotic-anesthetic actions of alpha 2 agonists from cyclic AMP in the rat.
Rabin BC; Guo TZ; Maze M
Pharmacol Biochem Behav; 1997; 57(1-2):23-9. PubMed ID: 9164550
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of nitric oxide metabolism enhances the hypnotic-anesthetic action of the alpha2-adrenoceptor agonist dexmedetomidine in vivo.
Tonner PH; Scholz J; Schlamp N; Schulte am Esch J
J Neurosurg Anesthesiol; 1999 Jan; 11(1):37-41. PubMed ID: 9890384
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of insulin secretion from rat pancreatic islets by dexmedetomidine and medetomidine, two sedatives frequently used in clinical settings.
Kodera SY; Yoshida M; Dezaki K; Yada T; Murayama T; Kawakami M; Kakei M
Endocr J; 2013; 60(3):337-46. PubMed ID: 23171706
[TBL] [Abstract][Full Text] [Related]
24. Dexmedetomidine injection into the locus ceruleus produces antinociception.
Guo TZ; Jiang JY; Buttermann AE; Maze M
Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
[TBL] [Abstract][Full Text] [Related]
25. Role of signal transduction in anesthetic action. Alpha 2 adrenergic agonists.
Maze M; Regan JW
Ann N Y Acad Sci; 1991; 625():409-22. PubMed ID: 1711813
[TBL] [Abstract][Full Text] [Related]
26. An isobolographic analysis of the hypnotic effects of combinations of dexmedetomidine with fentanyl or diazepam in rats.
Horváth G; Szikszay M; Rubicsek G; Benedek G
Life Sci; 1992; 50(23):PL215-20. PubMed ID: 1598062
[TBL] [Abstract][Full Text] [Related]
27. Nifedipine, an L-type calcium channel blocker, restores the hypnotic response in rats made tolerant to the alpha-2 adrenergic agonist dexmedetomidine.
Reid K; Guo TZ; Davies MF; Maze M
J Pharmacol Exp Ther; 1997 Dec; 283(3):993-9. PubMed ID: 9399968
[TBL] [Abstract][Full Text] [Related]
28. Adrenergic-cholinergic interactions in left atria: a study using K+ channel agonists, antagonist and pertussis toxin.
Ray A; MacLeod KM
Br J Pharmacol; 1990 Apr; 99(4):661-6. PubMed ID: 2163277
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of adenylate cyclase in the locus coeruleus mediates the hypnotic response to an alpha 2 agonist in the rat.
Correa-Sales C; Nacif-Coelho C; Reid K; Maze M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1046-9. PubMed ID: 1361568
[TBL] [Abstract][Full Text] [Related]
30. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.
Nelson LE; Lu J; Guo T; Saper CB; Franks NP; Maze M
Anesthesiology; 2003 Feb; 98(2):428-36. PubMed ID: 12552203
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
Bol CJJG ; Danhof M; Stanski DR; Mandema JW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
[TBL] [Abstract][Full Text] [Related]
32. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
Rabin BC; Guo TZ; Gregg K; Maze M
Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
[TBL] [Abstract][Full Text] [Related]
33. [Adrenergic receptor and alpha 2 agonist--4: Applied and clinical pharmacology of alpha 2 agonist].
Mizobe T
Masui; 1997 Aug; 46(8):1066-70. PubMed ID: 9283162
[TBL] [Abstract][Full Text] [Related]
34. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.
Levänen J; Mäkelä ML; Scheinin H
Anesthesiology; 1995 May; 82(5):1117-25. PubMed ID: 7741286
[TBL] [Abstract][Full Text] [Related]
35. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
Seidel WF; Maze M; Dement WC; Edgar DM
J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
[TBL] [Abstract][Full Text] [Related]
36. Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices.
Jorm CM; Stamford JA
Br J Anaesth; 1993 Sep; 71(3):447-9. PubMed ID: 8104450
[TBL] [Abstract][Full Text] [Related]
37. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
Hill CE; Powis DA; Hendry IA
Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
[TBL] [Abstract][Full Text] [Related]
38. Functional effects of activation of alpha-1 adrenoceptors by dexmedetomidine: in vivo and in vitro studies.
Schwinn DA; Correa-Sales C; Page SO; Maze M
J Pharmacol Exp Ther; 1991 Dec; 259(3):1147-52. PubMed ID: 1684815
[TBL] [Abstract][Full Text] [Related]
39. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
[TBL] [Abstract][Full Text] [Related]
40. The effect of pertussis toxin treatment on alpha-1-adrenoceptor-mediated pressor responses in the pithed rat: dependence on agonist efficacy but not chemical class.
Motley ED; Ruffolo RR; Nichols AJ
Pharmacology; 1992; 45(6):338-44. PubMed ID: 1362614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
